HOW TO MANAGE WEIGHT, HUNGER AND THE PROGRESSION TO DIABETES! (09-01-09)



Orlistat Inhibition of Intestinal Lipase Acutely Increases Appetite and Attenuates Postprandial Glucagon-Like Peptide-1-(7-36)-Amide-1, Cholecystokinin, and Peptide YY Concentrations

Quite a long title, but thought I’d leave it for effect. The bottom line is that, the use of drugs like Orlistat (and the over the counter blockbuster weight loss product called Alli) actually SLOW down the process the body uses to manage weight, hunger and the progression to diabetes!! Ugghhhh!!! Given the massive promotion of the release of Alli on the market some time ago we should expect further increases in obesity and diabetes any day now…Better make sure we double up on the artificial sweeteners.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Diabetes (Type 2)
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”